Izotziaja

Isotretinoin, the active ingredient in Izotziaja, is a retinoid presented as a topical formulation for skin use. It is prescribed for the treatment of acne vulgaris, including severe and nodular forms, and works by reducing sebaceous gland size, decreasing sebum output, and normalizing follicular keratinization.

GNH USA supplies Izotziaja as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide across multiple regions. The company follows strict quality standards and provides reliable global distribution to meet the needs of healthcare providers.

Izotziaja (isotretinoin) is used in dermatology to treat acne‑related conditions.

Acne vulgaris: reduces inflammatory lesions and prevents new breakouts. Severe nodular acne: decreases nodule size and number, improving skin appearance. Prevention of acne scarring: limits lesion formation that can lead to permanent scarring.

Topical isotretinoin may cause a range of skin reactions, varying from mild to severe.

Common Side Effects: - Dryness or peeling of the treated skin. - Redness or mild erythema. - Itching or burning sensation. - Increased sensitivity to sunlight.

Serious or Rare Side Effects: - Severe dermatitis or exfoliative skin reactions. - Allergic responses such as urticaria or angioedema. - Ocular irritation or conjunctivitis. - Systemic absorption leading to signs of hypervitaminosis A (rare). - Persistent or worsening inflammation requiring medical attention.

When prescribing or using Izotziaja, several safety considerations should be observed.

Pregnancy: contraindicated due to high teratogenic risk. Breastfeeding: not recommended as isotretinoin may be excreted in milk. Sun exposure: avoid excessive UV radiation and use sunscreen. Concurrent retinoids: avoid using other retinoid products to reduce irritation. Store at room temperature below 25°C: keep in the original pack, protect from moisture and light.

Isotretinoin can interact with other medications, affecting safety or efficacy.

Major Interactions (Avoid): - Systemic retinoids (e.g., oral isotretinoin): risk of cumulative toxicity. - Tetracycline antibiotics: increased photosensitivity. - Vitamin A supplements: risk of hypervitaminosis A.

Moderate Interactions (Monitor Closely): - Benzoyl peroxide: may heighten skin irritation. - Topical corticosteroids: can alter drug absorption. - Other topical irritants (e.g., salicylic acid): monitor for excessive dryness.